Tag: rebranding psychiatry

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

9
In Part 2 of our reader Q&A podcast, MIA founder Robert Whitaker answers questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.